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THE ROLE OF AF1Q IN NEURAL DEVELOPMENT 
YEYOON CHOI 
 
ABSTRACT 
ALL1-fused gene from chromosome 1q (AF1q) is a novel gene that 
encodes a 90-amino-acid protein that is unlike any other known proteins. AF1q 
was first discovered as a fusion partner for mixed-lineage leukemia in a pediatric 
acute myeloid leukemia. Since its discovery, AF1q has been found to act as an 
oncogene and has been linked to several solid neoplasms, including thyroid 
oncocytic tumors, breast cancer, testicular cancer, and colorectal cancer. AF1q is 
also upregulated in several hematological malignancies and is considered an 
adverse prognostic factor.  
In addition, AF1q is expressed in various regions of the brain throughout 
human neural developmental processes. The expression levels of AF1q and 
neuron-specific class III β-tubulin (Tuj1), a marker of post-mitotic neurons, are 
positively correlated in the cerebral cortex. AF1q expression also induces the 
transformation of human embryonic kidney cells into neurons, indicating that 
AF1q may play a key role in neuronal differentiation during normal neural 
development.  
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The activity of AF1q is regulated by RE1-silencing transcription factor 
(REST), an important regulator of embryonic and neural stem cells during 
normal development. Furthermore, AF1q is associated with the activity of the 
Wingless/Integrated (Wnt) signaling pathway, which is critical to normal 
development of the nervous system. Although the precise role of AF1q is yet to 
be uncovered, various studies have demonstrated that AF1q is indeed heavily 
involved in neurodevelopmental processes.  
The investigation of the role of AF1q in neurodevelopment is important 
for several reasons. First, it can give a better understanding of the biological and 
physiological functions of AF1q, a gene that is still poorly understood. Second, it 
can provide insight into the development of the human nervous system and the 
complex processes and regulations that are involved. Through the study of AF1q 
in a neurobiological context, its precise role in neural development may be 
uncovered, and new therapeutic approaches to neurodevelopmental disorders 
such as Down syndrome and Alzheimer’s disease may be possible.  
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INTRODUCTION 
 
 The development of the nervous system is a complex process involving 
numerous signaling molecules, proteins, and pathways. Though these 
complexities are being widely studied, there is much that is yet to be understood. 
A comprehensive understanding of neurodevelopmental process is crucial in 
several ways. For instance, it can elucidate the mechanisms behind various 
neurodevelopmental disorders to expand the possibilities of therapeutic 
treatments. Among many others, ALL1-fused gene from chromosome 1q (AF1q) 
is a novel gene that has been implicated in the development of the human 
nervous system. Although clear ties between AF1q and several malignancies 
have been studied, including acute myeloid leukemia and several cancers, its 
precise involvement in the development of the human nervous system is largely 
unclear. In this thesis, the role of the novel gene AF1q in neurodevelopment is 
discussed.  
An Overview of Neurodevelopment 
The human brain begins developing during the third week of gestation 
and continues through adolescence and possibly beyond. At the end of the 
second week of conception, the embryo is a two-layered structure consisting of 
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the epiblast cell layer and the hypoblast cell layer. By the end of the third week, 
the embryo undergoes gastrulation to become a three-layered structure (Figure 
1). The hypoblast layer eventually gives rise to extraembryonic tissues. The 
epiblast layer gives rise to three different lines of primary stem cells that 
eventually form the developing embryo. One of these stem cell lines is the 
neuroectodermal layer of stem cells, called neural progenitor cells, which form 
the nervous system (Stiles & Jernigan, 2010).  
 
Figure 1. Gastrulation. Gastrulation is a major event that occurs between E13 
and E20. Gastrulation begins with the formation of the primitive streak and 
the primitive node. Initially, there are the epiblast and hypoblast layers. The 
migrating cells in these layers move toward the primitive node and primitive 
streak. Eventually, the epiblast layer is replaced by the ectodermal layer, and 
the hypoblast layer is replaced by the endodermal layer. In between these 
layers, the mesodermal layer forms. Cells in the epiblast layer can also 
become neuroectodermal cells, which give rise to the nervous system. Ex = 
embryonic day x. Figure taken from (Stiles & Jernigan, 2010).        
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By the third week of gestation, the neural tube is formed.  The rostral 
region of the neural tube eventually forms the brain, whereas the caudal region 
of the neural tube develops into the hindbrain and the spinal column (Stiles & 
Jernigan, 2010). As neurulation advances, the anterior, middle and posterior 
brain vesicles develop. The anterior vesicles form the prosencephalon (precursor 
to the forebrain), which divides into the telencephalon and the diencephalon. The 
middle vesicle forms the mesencephalon, the precursor to the midbrain. Finally, 
the posterior vesicle forms the rhombencephalon (precursor to the hindbrain), 
which divides into the metencephalon and the myelencephalon (Stiles & 
Jernigan, 2010). These divisions characterize the primary organization of the 
central nervous system. 
During the embryonic period, along with dramatic morphological 
changes, there are numerous changes that contribute to a continuing process of 
neural patterning (Figure 2). This primitive patterning of the central nervous 
system is complex and involves molecular signaling. In addition to neural 
patterning, the most characteristic change during the fetal period is the formation 
of gyri and sulci by ordered folding (Stiles & Jernigan, 2010). 
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Figure 2. Morphological changes during the embryonic period. (A) The 
early embryonic period is marked by the formation of neural ridges. (B) 
The neural tube begins to form as the neural ridges fold. (C) The neural 
tube begins to close. (D) The neural tube continues to close in caudal 
(“tail”) and rostral (“head”) directions. (E) The primary vesicles emerge, 
including the prosencephalon, mesencephalon, and rhombencephalon. (F) 
The primary vesicles differentiate into secondary vesicles, including the 
telencephalon, diencephalon, metencephalon, and myelencephalon. Ex = 
embryonic day x. Figure taken from (Stiles & Jernigan, 2010).   
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Neuron production begins during the embryonic period, and cortical 
neurogenesis completes during the late embryonic period (E108) (Clancy, 
Darlington, & Finlay, 2001). The majority of neurons produced are located in the 
ventricular zone and contribute to the formation of the neocortex. Studies have 
shown that in early cortical neurogenesis, neural progenitor cells can produce 
any type of neuron. However, in later development, these neural progenitor cells 
gain fate restriction, and they are no longer capable of producing all neuronal 
types (Desai & McConnell, 2000).  
During development of the nervous system, apoptosis is present, with 
levels as high as 70% of cells in some layers of the cortex (Rabinowicz, de 
Courten-Myers, Petetot, Xi, & de los Reyes, 1996). There are also high levels of 
apoptosis noted among neural progenitor cells, and these levels increase in the 
ventricular zone throughout corticogenesis (Stiles & Jernigan, 2010). The exact 
reason for cell death is unknown, but studies have indicated that apoptosis may 
play an important role in the regulation of neural circuits, the correction of 
errors, and the elimination of cells of transient function (Buss & Oppenheim, 
2004; Buss, Sun, & Oppenheim, 2006; de la Rosa & de Pablo, 2000; Yeo & Gautier, 
2004). Postnatally, the nervous system continues to develop, but neurogenesis 
only continues to a limited extent.  
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Altogether, the development of the human nervous system is incredibly 
convoluted, with numerous proteins, pathways, and signaling molecules 
involved. Though there has been a vast improvement in the understanding of 
neurodevelopment in recent times, there is still much to be uncovered. Further 
investigation of the specific role of the gene AF1q in neurodevelopment may 
provide insight into neurodevelopmental processes and regulation.   
An Overview of AF1q  
ALL1-fused gene from chromosome 1q (AF1q), also known as 
myeloid/lymphoid or mixed-lineage leukemia; translocated to chromosome 11 
(MLLT11), is an intriguing gene located on chromosome 1 band 21 (Tse, Zhu, 
Chen, & Cohen, 1995). AF1q was first discovered as a mixed-lineage leukemia 
(MLL) fusion partner in an infant patient with acute myeloid leukemia, carrying 
the t(1;11)(q21;q23) translocation (Tse et al., 1995). The gene encodes a 9 kDa 
protein dissimilar to any known proteins and with a function poorly understood. 
Northern blot analyses have revealed that AF1q messenger RNA (mRNA) is 
expressed in various tissues, including high levels in the brain and thymus, as 
well as easily detectable levels in the colon and small intestine (Tse et al., 1995). 
However, despite its abundance in the thymus, AF1q is not detectable in mature 
hematopoietic tissues of the periphery. AF1q has been reported in hematological 
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malignancies and premalignant states such as myelodysplastic syndrome. AF1q 
has also been regarded as an oncogene involved in thyroid oncocytic tumors, 
breast cancer, testicular germ cell tumors, and colorectal cancer, among others 
(Hu et al., 2017). 
Following its discovery in a patient with acute myeloid leukemia, AF1q 
has been linked to various other hematological malignancies. AF1q is highly 
expressed in hematopoietic progenitor cells (Tse et al., 1995). Interestingly, 
clinical observations of patients with pediatric acute myeloid leukemia showed 
that increased expression of AF1q was associated with decreased survival of the 
patients (Tse et al., 2004). Similarly, elevated AF1q expression was found to be 
associated with poorer prognosis for adult patients having either 
myelodysplastic syndrome or acute myeloid leukemia and normal cytogenetics 
(Strunk et al., 2009; Tse et al., 2005). Higher AF1q expression in these patients 
was associated with worsened survival, implicating that AF1q may act as a 
prognostic marker or a direct contributor in hematological malignancies.  
 In normal human tissues, AF1q expression seems to be largely restricted 
to the thymus, the location at which differentiation of T cells occurs. However, 
AF1q expression has been found in all hematopoietic tumors, regardless of 
degree of differentiation. In fact, reverse transcription polymerase chain reaction 
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(RT-PCR) analyses demonstrated that AF1q mRNA is expressed in several 
different lines of leukemic cells (Figure 3) (Tse et al., 1995).  These studies 
showed that AF1q is, at the very least, an adverse prognostic factor in several 
hematological malignancies. Whether AF1q has a more direct role needs further 
investigation.  
Figure 3. Expression of AF1q in various leukemic cell lines. (A) RT-PCR 
analysis of AF1q expression was conducted at decreasing concentrations of AF1q 
mRNA (from left to right lanes). In addition, five leukemic cell lines were 
examined: CD34+ cells from the ALL line, Molt 13 cells from the  leukemic line, 
Jurkat cells from the leukemic T-cell line, B1 (pre-B) cells from the ALL line, and 
Duadi (B) cells from the leukemic ALL line. AF1q was expressed in all leukemic 
cell lines. (B) The RT-PCR analyses were quantified and normalized to the β-
actin expression levels. The relative quantitative values are demonstrated in this 
bar graph. AF1q = ALL1-fused gene from chromosome 1q; ALL = acute 
lymphoblastic leukemia; mRNA = messenger ribonucleic acid; RT-PCR = reverse 
transcription polymerase chain reaction. Figure taken from (Tse et al., 1995).   
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AF1q is regarded as an oncogenic factor and has been observed in various 
solid neoplasms. In particular, AF1q has been found to enhance platelet-derived 
growth factor receptor signaling, which in turn activates signal transducer and 
activator of transcription 3 (STAT3), a critical component in the pathway for 
cancer initiation and progression (Park et al., 2016). RT-PCR studies have shown 
that the AF1q gene is upregulated in thyroid oncocytic tumors (Jacques et al., 
2005). In addition, AF1q overexpression has been found in breast cancer. Human 
breast cancer cells, transfected with vectors expressing AF1q, enhanced the 
potential for these cells to proliferate and invade in vitro (Li et al., 2006). In vivo, 
these breast cancer cells grew faster and were more likely to metastasize, 
particularly to the lungs (Li et al., 2006). There is some evidence that AF1q may 
promote the potential of breast cancer cells to metastasize and invade through 
regulation of the matrix metalloproteinase (MMP) pathway and Rho C, a G 
protein involved in several signaling pathways (Li et al., 2006). Furthermore, 
studies of stem-like cells from breast cells with enhanced AF1q expression 
showed that AF1q may enhance the Wnt signaling pathway (Tse, Kim, & Park, 
2017). As the Wnt signaling pathway is a known regulator of stem cells and is 
involved with various cancers, AF1q may act on the Wnt pathway to promote 
cancer. Recently, AF1q expression has also been linked to colorectal cancer 
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tumorigenesis and progression (Hu et al., 2017). Moreover, upregulation of AF1q 
expression was found to be indicative of poorer prognosis in colorectal cancer 
patients (Hu et al., 2017).    
AF1q has also been found to have a pro-apoptotic role (Tiberio, Cavadini, 
Callari, Daidone, & Appierto, 2012). Specifically, it was discovered that AF1q 
increases apoptosis induced by doxorubicin, a therapeutic agent, through the 
BAD-mediated apoptotic pathway (Co et al., 2008). BAD (Bcl-2 antagonist of cell 
death) is a pro-apoptotic protein that is especially important in radiation-induced 
apoptosis (Co et al., 2008). As drug-induced apoptosis is hypothesized to play a 
role in the development of drug resistance, the role of AF1q as an apoptotic 
regulator is of interest. In addition, it has been found that AF1q increases 
radiation-induced apoptosis by upregulating nuclear factor-κB (NF-κB) protein, 
which increases BAD to activate the apoptotic pathway (Co et al., 2010). As NF-
κB is found to be involved in carcinogenesis of various types, the interaction of 
AF1q with NF-κB is of interest in uncovering the oncogenic function of AF1q. 
Moreover, the role of AF1q in the upregulation of radiation-induced apoptosis 
proposes that AF1q may be important in cancer therapy (Co et al., 2010).   
Studies of AF1q have shown that AF1q plays an important role in B-cell 
versus T-cell differentiation. Hematopoietic progenitor cells (HPCs) transduced 
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with AF1q were found to have decreased percentages of CD19+ B cells (Parcelier 
et al., 2011). This indicated that AF1q acts as an antagonizing factor that prevents 
HPCs from entering the B-cell pathway. In contrast, percentages of T cells were 
augmented. This study further discussed how AF1q interacts with the Delta-
like/Notch signaling pathway in order to promote emergence of prothymocytes 
in the bone marrow as well as T-cell development (Parcelier et al., 2011). Thus, 
AF1q clearly acts as a regulator of lymphoid development and plays an 
important role in cell fate specification.   
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DIFFERENTIAL EXPRESSION OF AF1Q IN DEVELOPING NEURONS 
 
To better understand the role of AF1q in neurodevelopmental processes, 
Yamada, Clark, and Iulianella (2014) explored the spatio-temporal expression 
pattern of AF1q throughout the development of the peripheral and central 
nervous systems. Using mouse neurogenesis as a model, this study 
demonstrated that AF1q is a marker of the emergence of post-mitotic neurons in 
the central and peripheral nervous systems. In situ hybridization and 
immunohistochemistry were utilized to localize the expression of AF1q in 
various areas of the nervous system (Yamada et al., 2014). 
The Cranial Ganglia  
Throughout the early stages (approximately days 10-11) of embryonic 
development, AF1q mRNA was detected in the facio-acoustic ganglion complex, 
trigeminal ganglion, glossopharyngeal ganglion, superior and inferior vagus 
ganglia, dorsal root ganglia, and the otic vesicle (Figure 4) (Yamada et al., 2014). 
In addition to the ganglia, expression was seen in the forebrain, midbrain, and 
hindbrain. Furthermore, areas in which AF1q was detected were also positive for 
Tuj1 expression (Yamada et al., 2014). Because Tuj1 is a β-tubulin that is 
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specifically expressed in post-mitotic neurons, it is thus a useful marker of 
neurogenesis. 
 
 
Figure 4. Expression of AF1q in the embryo. (A) In situ hybridization shows 
expression of AF1q mRNA in the facio-acoustic ganglion complex at E9.5. 
Sense and antisense riboprobes show staining for AF1q expression in the 
telencephalon (Te) and the otic vesicle (ov). (A’) Tuj1 is detected, indicative of 
post-mitotic neurons. (B) In situ hybridization shows AF1q expression at 
E10.5 in the otic vesicle, hindbrain, midbrain, and telencephalon. (B’) AF1q 
expression is notable in the basal region of the forebrain, midbrain, and 
hindbrain. (C) In situ hybridization shows AF1q expression in the spinal 
cord, dorsal root ganglion, and marginal zone. AF1q = ALL1-fused gene from 
chromosome 1q; DRG = dorsal root ganglia; Ex = embryonic day x; Hb = 
hindbrain; IX = glossopharyngeal ganglion; Mb = midbrain; MZ = marginal 
zone; Tuj1 = neuron-specific class III β-tubulin; V = trigeminal ganglia; VII-
VIII = facio-acoustic complex; VZ = ventricular zone; X = vagus ganglion. 
Scale bars: 1 mm (A, B). Figure taken from (Yamada et al., 2014).  
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The Developing Cortex  
AF1q was detected in the outer telencephalon, the marginal zone at which 
mature cortical neurons first emerge, as well as the lateral ganglionic eminence 
around embryonic day 10 to embryonic day 11 (Yamada et al., 2014). Around 
embryonic days 15 to 16, AF1q was detected in the cortical plate and subplate. 
Additionally at this time, there was faint expression of AF1q in the intermediate 
zone of the developing cortex (Figure 5). In all these areas in which AF1q 
expression was found, Tuj1 was also co-expressed.    
The Spinal Cord 
AF1q expression was found in the ventral root ganglion and the dorsal 
root ganglion. AF1q expression then expanded to interneurons in the marginal 
zone of the spinal cord and the dorsal root ganglion, and was especially 
prominent in the lateral motor column of the ventral horn (Yamada et al., 2014). 
The pronounced expression of AF1q in the embryonic spinal cord demonstrates 
that AF1q expression is specific for post-mitotic spinal cord neurons and is 
involved in motor neuron development. 
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Figure 5. Expression of AF1q during corticogenesis. (A) AF1q expression is 
detectable at the marginal zone, lateral ganglionic eminence, and the floorplate 
at E11.5. (A’) At higher magnification, AF1q expression is also seen in the 
marginal zone. (A’’) Immunohistochemistry shows that the marginal zone is 
positive for Tuj1, a marker of post-mitotic neurons, whereas the ventricular 
zone is positive for Sox2, a marker of neural progenitors. (B) At E13.5, AF1q 
expression is localized to the marginal zone and lateral ganglionic eminence. 
(B’) At higher magnification, AF1q expression is noted in the marginal zone and 
preplate. (B’’) The marginal zone and preplate are positive for Tuj1. (C-C’) At 
E16.5, AF1q is visible in the cortical plate and the subplate. (C’’) 
Immunohistochemistry with Sox2, Tuj1, and DAPI allows identification of the 
newly formed cortical layers. AF1q = ALL1-fused gene from chromosome 1q; 
CP = cortical plate; CTX = cortex; DAPI =  4′,6-diamidino-2-phenylindole; Ex = 
embryonic day x; FP = floorplate; IZ = intermediate zone; LGE = lateral 
ganglionic eminence; MLLT11 = myeloid/lymphoid or mixed-lineage leukemia; 
translocated to chromosome 11; MZ = marginal zone; PP = preplate; SP = 
subplate; Sox2 = sex-determining region Y-box 2; Tuj1 = neuron-specific class III 
β-tubulin; VZ = ventricular zone. Scale bars: 80 μm (A, B); 40 μm (A’, B’, C). 
Figure taken from (Yamada et al., 2014).       
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 The Eye  
Ganglion cells and amacrine cells are the first mature cells to appear 
during mouse eye development (Cayouette, Poggi, & Harris, 2006; Hinds & 
Hinds, 1974). They were present on the inner surface of the neural retina around 
embryo days 10-13 (Figure 6). These cells continually localized toward the 
innermost layer of the retina. Around day 11.5, AF1q was not detectable in the 
inner layer of the retina. However, around day 13.5, AF1q expression appeared 
in this inner retinal layer (Figure 6). At day 16.5, AF1q was extensively localized 
to the inner retinal neuroepithelium and optic nerve (Yamada et al., 2014). Tuj1 
was co-localized to regions of AF1q expression throughout this entire process of 
eye development. This co-expression demonstrates that AF1q is expressed in 
post-mitotic neurons of the developing eye in the mouse model.  The expression 
of AF1q throughout retinal neurogenesis in the mouse proposes the hypothesis 
that AF1q may play an important role in the development of the retina.    
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Figure 6. Expression of AF1q in the eye.  (A) AF1q is not detectable at E11.5 
through immunohistochemistry, but Tuj1 cells are present in the inner retinal 
layer. (B) In situ hybridization at E13.5 shows AF1q expression in the retinal 
neuroepithelium of the developing eye. (C) AF1q expression coincides with 
Tuj1 expression in the developing eye at E13.5. (D-D’’) Immunohistochemistry 
shows co-localization of AF1q and Tuj1 in the inner retinal layer at E13.5. (E-
E’’) Immunohistochemistry shows continued co-localization of AF1q and Tuj1 
at E13.5 in the inner retinal layer. AF1q = ALL1-fused gene from chromosome 
1q; Ex = embryonic day x; Ls = lens; MLLT11 = myeloid/lymphoid or mixed-
lineage leukemia; translocated to chromosome 11; ON = optic nerve; Rne = 
retinal neuroepithelium; Sox2 = sex-determining region Y-box 2; Tuj1 = 
neuron-specific class III β-tubulin. Scale bars: 50 μm (A-C); 20 μm (D-D’’); 100 
μm (E-E’’). Figure taken from (Yamada et al., 2014). 
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The Enteric Nervous System  
During embryogenesis, neural crest cells migrate to form the enteric 
nervous system. Although AF1q was not detected in enteric neural crest cells in 
early embryogenesis, expression was seen in mature enteric neurons located in 
the outer and inner developing circular muscle layers (Yamada et al., 2014). Tuj1 
was expressed as well, indicating the post-mitotic state of these neurons. The 
neurons in the outer and inner developing circular muscle layers are those that 
later form the Auerbach’s (myenteric) plexus. 
Nucleo-Cytoplasmic Localization 
In developing neurons, AF1q expression was detected mostly in the 
cytoplasm, though there was some localization to the nucleus. For example, 
immunohistochemistry analysis showed high AF1q expression in the cytoplasm 
of neurons of the marginal zone in the dorsal forebrain at E11.5 (Yamada et al., 
2014). This observation was replicated in cells of the same region at E13.5 and 
E16.5 (Yamada et al., 2014). On the other hand, AF1q expression was observed at 
only low levels in the soma of the neurons in the marginal zone at E11.5 (Yamada 
et al., 2014). These findings showed that in developing neurons, AF1q was highly 
expressed in the cytoplasm but not in the nucleus. This raises the possibility that 
 19 
nucleo-cytoplasmic shuttling of AF1q may occur during neurodevelopment 
(Yamada et al., 2014).  
Neuronal Cell Culture 
In another study which corroborated the findings that AF1q is a neural 
marker, dissociated neural stem cell/progenitor cells were obtained from mouse 
embryonic cerebral cortex (Lin et al., 2004). Bromodeoxyuridine (BrdU) was used 
as a marker of proliferation, and Tuj1 was used as a marker of neurons. Neural 
stem cells from the cerebral cortex of an embryo at day 11 (E11) were obtained 
and cultured.  
In Figure 7, quantitative analysis showed that initially, the dissociated 
neural stem cells stained heavily for BrdU, indicating the presence of mainly 
proliferative cells in neural stem cells taken from E11 cerebral cortex and 
expanded in vitro for 0 days (E11-D0). At E11-D0, about 98% of the total 
population of cells were proliferative neural stem cells. Throughout the period of 
in vitro cell culture, the amount of staining for Tuj1 increased, indicating the 
increasing appearance of neurons in the cell population. From E11-D0, E11 
neural stem cells expanded in vitro for 0 days, to E11-D10, E11 neural stem cells 
expanded in vitro for 10 days, the percentage of BrdU staining cells clearly 
decreased. Conversely, the percentage of Tuj1 staining cells increased from E11-
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D0 to E11-D10 cells. In comparison, the culture of dissociated neurons obtained 
from E15-D10 (neural stem cells taken from E15 and expanded in vitro for 10 
days) contained 98% neurons expressing Tuj1 (Lin et al., 2004).  
 
 
 
Figure 7. Analysis of neuronal population throughout cell culture. BrdU 
was used as a marker of proliferating neural stem cells, and Tuj1 was used 
as a marker of neuronal cells. At E11-D0, 98% of the cells were proliferative 
stem cells. At E11-D4, the percentage of Tuj1 positive neurons increased to 
5%, and by E11-D10, to 20%. Cell culture of E15-D10 showed 98% neurons. 
BrdU = bromodeoxyuridine; Ex-Dy = embryonic day x- cultured in vitro for 
y days; Tuj1 = neuron-specific class III β-tubulin. Figure taken from (Lin et 
al., 2004).   
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The Lin et al. (2004) study also included Western blot analyses which 
revealed that AF1q was an upregulated gene in the E11-D4, E11-D10, and E15-
D10 neuronal cultures (Figure 8A). The highest concentration of AF1q was seen 
in the neuronal cultures. This demonstrated that the expression level of AF1q 
and the amount of neurons are positively correlated. In addition, AF1q 
expression was examined in cells from the E15 mouse cortex, E15 mouse thymus, 
and E15 mouse liver. Cells from the E15 mouse cortex contain mostly neurons 
and astrocytes. Western blot analysis showed that of these different types of cells, 
those of the E15 cortex had the highest expression level of AF1q (Figure 8B). 
These findings are consistent with previous conclusions regarding the positive 
correlation between AF1q expression and neuron levels.  
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Figure 8. Western blot analysis of AF1q expression. (A) The expression level 
of AF1q increases from left to right, with E11-D0 having the lowest 
concentration and E15-D10 having the highest concentration. As previously 
discussed, E15-D10 has the highest percentage of neurons, whereas E11-D0 
has the lowest. This reveals that AF1q expression is correlated to the amount 
of neurons present in the cell culture. GAPDH, the housekeeping gene, was 
relatively constant for all. (B) AF1q expression was analyzed in dissociated 
neurons (E11-D0) and dissociated cells from E15 cortex (E15-C), thymus (E15-
T), and liver (E15-L). Dissociated cells had the highest expression level of 
AF1q. Given that dissociated cells of the cortex are mainly neurons, this 
supports the conclusion that AF1q neuron expression levels are correlated. 
AF1q = ALL1-fused gene from chromosome 1q; bp = base pair; Ex-Dy = 
embryonic day x – cultured in vitro for y days; GAPDH = glyceraldehyde 3-
phosphate dehydrogenase; M = molecular-weight size marker. Figure taken 
from (Lin et al., 2004).      
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THE ROLE OF AF1Q IN NEURONAL DIFFERENTIATION 
 
Studies suggest the possibility that AF1q may have an important role in 
neuronal differentiation during the development of the nervous system. In one 
such study, human embryonic kidney (HEK) cells were utilized to investigate 
this function of AF1q (Lin et al., 2004). The findings from the study highlighted 
the ability of AF1q to trigger neuronal differentiation and further supported the 
hypothesis that AF1q is an integral player in neurodevelopmental processes. 
Ectopic Expression of AF1q Triggers Neuronal Differentiation 
In the study by Lin and colleagues (2004), two plasmids, pIRES-GFP-AF1q 
and pIRES-GFP, were created to investigate the function of AF1q. The plasmid 
pIRES-GFP-AF1q was a bicistronic construct that expressed both green 
fluorescent protein (GFP) and AF1q, whereas p-IRES-GFP expressed only green 
fluorescent protein. HEK cells were obtained and transfected with either pIRES-
GFP-AF1q or pIRES-GFP. Immunohistochemistry was then used to visualize the 
expression of either of the specific protein markers (Lin et al., 2004).  
Figure 9 shows the results of this study by Lin et al. (2004). HEK cells 
transfected with pIRES-GFP and pIRES-GFP-AF1q plasmids both appeared 
green because of the presence of green fluorescent protein (Figure 9A,D). 
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However, the pIRES-GFP-AF1q transfected HEK cells also appeared red, in 
addition to green, indicating expression of Tuj1 (Figure 9E,F). On the other hand, 
there was no Tuj1 expression in HEK cells transfected with pIRES-GFP (Figure 
9B,C). As Tuj1 is an effective neuronal marker, this demonstrated that in pIRES-
GFP-AF1q transfected HEK cells, a portion of the HEK cells differentiated into 
neurons. In essence, ectopic expression of AF1q stimulated the expression of Tuj1 
through the transformation of neurons from HEK cells. However, less than 1% of 
the transfected HEK cells appearing green were also notable for Tuj1 expression. 
The relatively limited extent of neuronal differentiation in this experiment 
demonstrated that specific genes, proteins, and a proper microenvironment may 
be crucial to facilitate cellular transformation (Lin et al., 2004). Nevertheless, 
these findings provided compelling evidence that AF1q expression triggers 
neuronal differentiation.  
Although the precise role of AF1q remains elusive, this study indicated 
that AF1q clearly plays a part in the differentiation of neurons. In embryonic 
development of the nervous system, AF1q may function in the normal 
differentiation of progenitor cells into neurons and thus may serve as an 
important contributor to neurodevelopmental processes.    
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Figure 9. HEK cells transfected with AF1q differentiate into neurons. (A-C) 
HEK cells were transfected with the control plasmid, pIRES-GFP. These cells 
express GFP but do not express Tuj1. (D-F) HEK cells were transfected with the 
pIRES-AF1q-GFP plasmid, which causes the cells to express AF1q. These cells 
are positive for GFP expression as well as Tuj1 expression. This demonstrates 
that the induced expression of AF1q in non-neuronal HEK cells triggered the 
expression of Tuj1. AF1q expression induced the HEK cells to become neuronal 
cells. AF1q = ALL1-fused gene from chromosome 1q; GFP = green fluorescent 
protein; HEK = human embryonic kidney; Tuj1 = neuron-specific class III β-
tubulin. Scale bar: 10 μm (A-F). Figure taken from (Lin et al., 2004).    
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REGULATION OF AF1Q IN NEURODEVELOPMENT 
 
 An understanding of how AF1q is regulated, as well as how AF1q is 
involved in molecular signaling, may provide valuable insight into the role of 
AF1q in neurodevelopment. In this section, RE1-silencing transcription factor 
(REST) and its relationship with AF1q are discussed. As REST is widely known 
to act as a regulator of embryonic and neural stem cells, this factor is crucial to 
normal neurodevelopmental processes. The involvement of AFq1 with REST 
corroborates the hypothesis that AF1q is also integral to neurodevelopment.   
About REST  
RE1-silencing transcription factor (REST) is a known regulator of 
embryonic and neural stem cells in humans. It acts by binding to the RE1-
binding site/neuron-restrictive silencer element (RE1/NRSE) to regulate the 
transcription of downstream genes throughout neurodevelopment (Chong et al., 
1995). In fact, REST can regulate target genes by acting as a transcriptional 
silencer or activator (Chong et al., 1995). Thus, REST plays an important role in 
regulating embryonic and neural stem cells and is clearly necessary for proper 
neural development.  
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In addition, it has been found that the expression of REST is correlated to 
neurodevelopmental disorders. For example, studies of human fetal Down 
syndrome brains and mouse Down syndrome brains revealed a decreased 
expression of REST (Bahn et al., 2002; Canzonetta et al., 2008). Similarly, REST 
expression was decreased in brains of Alzheimer’s disease patients (Lu et al., 
2014). As such, REST has been noted as a protective factor for neurodegenerative 
diseases and aging. Consequently, REST and its target genes have important 
clinical significance in the treatment of neural disorders and diseases.   
Besides its role in neurodevelopment, REST has an important role in 
neurogenesis. Downregulation of REST is needed for normal neuronal 
differentiation to proceed (Juhila et al., 2011). Conversely, overexpression of 
REST leads to disturbance in the appropriate expression and function of neurons 
and axons. In fact, REST was found to regulate numerous normal neuronal 
processes by modulating the expression of critical neurotransmitter receptors as 
well as synaptic and ion channel proteins (Bahn et al., 2002; Chong et al., 1995). 
Interestingly, REST was also found to regulate the expression of AF1q. Given the 
extensive role of REST in the regulation of neurodevelopmental processes, this 
finding on its regulation of AF1q expression raises the possibility that AF1q also 
has a role in neurodevelopment. 
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REST Negatively Regulates AF1q 
In one study, the question of whether REST regulates AF1q gene 
transcription was investigated (Hu, Sun, Zhang, Sha, & Sun, 2015). The findings 
from this study demonstrated that REST modulates the expression of AF1q by 
acting as a transcriptional regulator. These results were based on experiments 
using human embryonic kidney (HEK) cells transfected with either pREST, a 
plasmid with REST expression, or psiREST, a plasmid with REST expression 
silenced. Based on RT-PCR analysis, this transfection showed that cells with 
psiREST reduced the expression of REST, confirming the efficiency of the 
plasmid. RT-PCR and Western blot analyses were then used to show that 
overexpression of REST, modeled by HEK cells transfected with pREST, had a 
reduced amount of AF1q mRNA (Figure 10). Conversely, for HEK cells 
transfected with psiREST, the absence of REST increased the amount of AF1q 
mRNA (Figure 10). The reciprocal relationship between REST and AF1q 
expressions indicated that elevated REST expression represses AF1q 
transcription, whereas reduced REST expression increases AF1q transcription. 
Consequently, it can be deduced that REST acts as a negative regulator of AF1q 
gene transcription (Hu et al., 2015). 
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The Hu et al. (2015) study also cloned the 5’ untranslated region of the 
AF1q gene and inserted it into a promoterless vector. Transfection of this vector 
into HEK cells demonstrated AF1q promoter activity, revealing that the AF1q 
promoter was located in the 1811-base pair fragment of the 5’ untranslated 
region of the AF1q gene. HEK cells were then transfected with both the vector 
containing the promoter and pREST, in varying ratios of pREST to AF1q 
Figure 10. REST represses AF1q expression.  RT-PCR and Western blot 
analyses revealed that AF1q mRNA levels were repressed in the presence of 
overexpressed REST in HEK cells. In the absence of REST expression 
(siREST), AF1q expression is very high. The difference between AF1q 
expression when REST is overexpressed and when REST is silenced is 
significant. β-actin was used as an internal control for the experiment. AF1q 
= ALL1-fused gene from chromosome 1q; Con = control; HEK = human 
embryonic kidney; mRNA = messenger ribonucleic acid; REST = RE1-
silencing transcription factor; RT-PCR = reverse transcription polymerase 
chain reaction. Plotted values = mean ± SE (n = 3); *p < 0.01. Figure taken 
from (Hu et al., 2015). 
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promoter. Western blot analyses showed that the highest transfected pREST to 
AF1q promoter ratio had the least AF1q promoter activity, whereas the lowest 
transfected pREST to AF1q promoter ratio had the highest AF1q promoter 
activity (Figure 11). These results demonstrated that the AF1q promoter is indeed 
regulated by REST in a negative manner (Hu et al., 2015). REST inhibits the 
transcription of AF1q by decreasing the activity of the AF1q promoter.  
The AF1q Promoter Has an NRSE Site 
Previous studies have shown that REST acts as a transcription factor by 
binding to an RE1-binding site/neuron-restrictive silencer element (RE1/NRSE), 
which is a 21-base pair sequence (Hu et al., 2015). This implies that the 5’ 
untranslated region of the AF1q gene containing the AF1q promoter must have 
an NRSE site for REST to bind, given that REST acts as a transcription factor 
controlling the expression of AF1q. A computer-based analysis of the 5’ 
untranslated region of the AF1q gene revealed two possibilities for the NRSE site 
at either the -383 to -363 base pair region or the +422 to +442 base pair region (Hu 
et al., 2015). Plasmids containing deletions of either region were constructed and 
then co-transfected with plasmids expressing REST into HEK cells. The 
transfection with the deletion in the -383 to -363 base pair region showed 
significantly decreased activity of the AF1q promoter, whereas the transfection  
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with the deletion in the +422 to +442 base pair region showed unaffected AF1q 
promoter activity (Hu et al., 2015). This finding indicated that of the two 
possibilities, the NRSE site at which REST binds must be located in the -383 to -
363 base pair region of the AF1q promoter. The identification of the NRSE site at 
Figure 11. REST inhibits AF1q promoter activity. HEK cells transfected 
with REST and the AF1q promoter (REST + pAF1q promoter) had 
significantly less promoter activity, measured by a luminometer to monitor 
dual-luciferase activity, compared with HEK cells transfected with a control 
and AF1q promoter (Con + pAF1q promoter). As the transfected mass ratio 
of REST to AF1q promoter increased, ranging from 1:3 to 5:1 (going from 
left to right), the relative overexpression of REST decreased the AF1q 
promoter activity. This demonstrates that REST represses AF1q promoter 
activity in a concentration dependent manner. Increased concentrated of 
REST relative to AF1q promoter results in an even greater reduction in AF1q 
promoter activity. AF1q = ALL1-fused gene from chromosome 1q; Con = 
control; HEK = human embryonic kidney; pGL3Basic = promoterless vector; 
REST = RE1-silencing transcription factor; RLU = relative light unit. Plotted 
values = mean ± SE (n = 3); *p < 0.01. Figure taken from (Hu et al., 2015).    
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which REST binds the AF1q promoter confirms previous findings that REST acts 
as a transcriptional regulator of AF1q expression.  
AF1q and REST During Neurodevelopment  
Previous studies have demonstrated that REST regulates embryonic and 
neural stem cells and is thus important in early development (Chong et al., 1995). 
AF1q has also been found to be highly expressed in various regions of the brain 
throughout early embryonic development of the nervous system (Yamada et al., 
2014). This raises the possibility that AF1q and REST interact with one another 
during neurodevelopment. To study this hypothesis, Hu and co-workers (2015) 
extracted RNA from mouse brains at days 13.5 and 18 of the embryonic stage, at 
days 1, 7, and 14 of the postnatal stage, and at the adult stage. RT-PCR was 
conducted to measure mRNA levels of AF1q and REST during each of these 
stages. Interestingly, at all stages, the mRNA levels of AF1q and REST 
demonstrated a significant negative relationship (Figure 12). During embryonic 
development in which there is significant neurodevelopment, AF1q levels were 
high, whereas REST levels were low. These results confirmed the finding that 
REST acts as a negative regulator of AF1q expression. Furthermore, they 
demonstrated that AF1q is highly expressed in the brain throughout embryonic 
development and is negatively regulated by REST (Hu et al., 2015). Though the 
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precise role of AF1q remains elusive, it is conclusive that AF1q is highly 
expressed during embryonic neurodevelopment. In addition, given that AF1q is 
regulated by REST, a transcriptional factor that is important in neurogenesis and 
normal synaptic and neuronal functioning, it can be hypothesized that AF1q is 
integral to these processes as well.  
 
Figure 12. AF1q is negatively correlated with REST. The expression of 
AF1q and REST was observed in the mouse brain from embryonic day 13.5 
(E13.5) to adulthood. At each time point, one or more mice were used, as 
indicated by the number after the hyphen. These observations demonstrate 
that throughout mouse neurodevelopment, the levels of AF1q and REST 
have a negative relationship. AF1q = ALL1-gene fused from chromosome 
1q; Ex-y = embryonic day x – mouse y; mRNA = messenger ribonucleic 
acid; Px-y = postnatal day x - mouse y; REST = RE1-silencing transcription 
factor. Spearman correlation: p = 0.0010, ρ = -0.8182. Figure taken from (Hu 
et al., 2015). 
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AF1Q AND THE WNT SIGNALING PATHWAY 
 
 Wnt signaling is a well-known pathway that controls various important 
molecular processes. Dysregulation of the Wnt pathway has been linked to 
abnormalities and diseases, including various types of cancer (Nusse & Varmus, 
1982). Interestingly, Wnt signaling has also been found to play a crucial role in 
normal embryonic development, which includes neurodevelopmental processes 
(Ciani & Salinas, 2005). In addition, through studies of kidney damage and breast 
cancer, it has been discovered that AF1q interacts with the Wnt signaling 
pathway (Zhang et al., 2017). Given that Wnt signaling is vital to normal 
neurodevelopment and that AF1q interacts with Wnt signaling, these findings 
raise the possibility that AF1q may influence neurodevelopment through the 
Wnt pathway.      
Overview of the Wnt Signaling Pathway  
Wnt1 was originally identified as a proto-oncogene involved in mammary 
tumor formation and development (Nusse & Varmus, 1982). Since then, 
extensive studies have demonstrated a variety of other roles of Wnt proteins, 
including intercellular communication, cell proliferation, cell polarity, cell 
movement, and programmed cell death (Ciani & Salinas, 2005). Furthermore, 
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recent studies have shown the involvement of Wnt in normal embryonic 
development of the nervous system. Wnt signaling may also be involved in stem 
cell maintenance as well as neuronal processes like circuits and plasticity 
(Kiecker & Niehrs, 2001b; Stern, 2001).  
Wnt pathways can be categorized into three types: the canonical or Wnt/-
catenin pathway, the planar cell polarity (PCP) pathway, and the Wnt/calcium 
pathway (Figure 13). In the canonical pathway (Figure 13A), Wnt signaling 
regulates early cell fate decisions (Ciani & Salinas, 2005). Wnt signaling regulates 
the expression of -catenin, which then mediates the transcription of T-cell 
specific transcription factor (TCF). TCF activates the transcription of various 
downstream genes that act in the control of early cell fate decisions. The -
catenin-mediated canonical pathway is of particular interest in 
neurodevelopment because canonical Wnt signaling controls the patterning of 
the nervous system during development. It has been proposed that the canonical 
pathway may also regulate synaptogenesis (Ciani & Salinas, 2005)  
The planar cell polarity pathway (Figure 13B) is involved in the control of 
cell polarity and movement during gastrulation, within the epithelium, and 
within the cochlea of the ear (Ciani & Salinas, 2005). The planar cell polarity 
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pathway is hypothesized to act on the actin cytoskeleton and microtubules to 
regulate cell behavior (Ciani & Salinas, 2005).  
The third type of Wnt pathway, called the Wnt/calcium pathway (Figure 
13C), is also involved in cell movement during gastrulation and heart 
Figure 13. The three types of Wnt signaling pathways. There are three main 
types of Wnt pathways: (A) the canonical or Wnt/β-catenin pathway, (B) the 
planar cell polarity (PCP) pathway, and (C) the Wnt/calcium pathway. APC = 
adenomatosis polysis coli; CaMKII = calcium/calmodulin-dependent protein 
kinase II; DVL = disheveled; FZ = frizzled; GSK3β = glycogen synthase kinase 
3β; JNK = c-Jun amino-terminal kinase; LEF = lymphoid-enhancing factor; 
LRP5/6 = low-density lipoprotein receptor-related protein 5/6; PCP = planar 
cell polarity; PKC = protein kinase C; TCF = T-cell specific transcription factor. 
Figure taken from (Ciani & Salinas, 2005).   
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development (Ciani & Salinas, 2005). This signaling pathway causes the influx of 
calcium following Wnt-induced activation (Ciani & Salinas, 2005).   
Wnt Signaling and Neurodevelopment 
Wnt signaling in relation to neurodevelopment is well studied. There are a 
variety of ways in which Wnt signaling processes influence the normal 
development and patterning of the nervous system. Studies have demonstrated 
that the -catenin-mediated activation of Wnt signaling regulates neural tube 
patterning (Kiecker & Niehrs, 2001a; Nordström, Jessell, & Edlund, 2002). 
Together with several other regulatory factors, Wnt induces the regional 
patterning of the anterior to posterior neural tube during embryonic 
development (Ciani & Salinas, 2005). Complex regulation and inhibition of the 
Wnt signaling is also involved in the regionalization and patterning of the 
forebrain. In studies of zebrafish, it was proposed that Wnt inhibition is required 
for the division of the forebrain into the telencephalon, the eye field, and the 
hypothalamus during neurodevelopment (Heisenberg et al., 2001). Wnt signaling 
also regulates later developmental processes of the nervous system, including 
hippocampal development, formation of the midbrain-hindbrain boundary, and 
hindbrain development (Ciani & Salinas, 2005). In addition, Wnt signaling 
regulates the formation, proliferation, and cell fate decisions of neurons in the 
 38 
spinal cord. Extensive studies demonstrated the role of Wnt in dendrite 
morphogenesis and synapse formation as well (Ciani & Salinas, 2005).  
Altogether, the results are clear that among its many roles in biology, Wnt 
signaling plays an integral part in the normal development and patterning of the 
nervous system. It would be interesting to conduct future studies to investigate 
the relationship between AF1q and Wnt signaling, as well as if and how they 
interact to influence neurodevelopmental processes.     
AF1q and Kidney Damage by the Wnt Pathway   
AF1q has been linked to the -catenin-mediated canonical Wnt pathway. 
In one study, AF1q was found to activate Wnt signaling, leading to downstream 
injury of podocytes in the kidney (Zhang et al., 2017). Podocytes are involved in 
the normal functioning of the glomerulus, and injury can lead to ineffective 
glomerular filtration, proteinuria, and eventual kidney disease (Nagata, 2016). In 
the study by Zhang and colleagues (2017), Adriamycin (ADR) treatment was 
administered to mice, inducing podocyte injury. Postmortem analyses of the 
glomeruli of these mice showed significantly higher levels of AF1q mRNA than 
found in mice without ADR treatment. This result raised the hypothesis that 
ADR-induced kidney injury acts through AF1q. This hypothesis was confirmed 
by knocking out AF1q in ADR-induced mice. Interestingly, these mice did not 
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exhibit podocyte injury, confirming the hypothesis that podocyte injury requires 
the presence of AF1q (Zhang et al., 2017).  
  
Figure 14. AF1q contributes to podocyte injury. Mouse podocyte (MPC5) 
cells were transfected with AF1q. When compared with the control, the 
protein levels of desmin and snail, markers of podocyte injury, were 
increased in the AF1q transfected cells. Conversely, E-cadherin, WT1, and 
nephrin, markers of podocyte function, were decreased in AF1q transfected 
cells. The differences in protein levels between control and AF1q transfected 
cells were significant for all types of proteins. These findings demonstrate 
that AF1q plays a role in injury of the podocyte. AF1q = ALL1-fused gene 
from chromosome 1q; CON = control; MPC5 = mouse podocyte cell 5; WT1 
= Wilms’ tumor suppressor gene. Plotted values = mean ± SD; *p < 0.05, **p 
< 0.01. Figure taken from (Zhang et al., 2017).   
 40 
In addition, protein levels of desmin and snail, which are both known 
markers of podocyte injury, were elevated in AF1q overexpressing cells. 
Conversely, protein levels of Wilms’ tumor suppressor gene (WT1), nephrin, and 
E-cadherin, which are known markers of podocyte functioning, were decreased 
in AF1q overexpressing cells (Figure 14) (Zhang et al., 2017). Histological 
staining confirmed the relationship between AF1q overexpression and kidney 
damage. Also, levels of -catenin, an important protein in the canonical pathway 
of Wnt signaling, were notably enhanced in AF1q overexpressed cells with 
podocyte injury (Figure 15) (Zhang et al., 2017). This result suggests that AF1q 
mediates kidney damage by acting on the canonical Wnt pathway.  
In fact, it was found that AF1q acts on the canonical Wnt pathway by 
interacting with T-cell specific transcription factor 7 (TCF7) and activating 
transcription of CD44, a transmembrane glycoprotein that acts as a Wnt target 
gene and a Wnt pathway regulator (Park et al., 2015). This finding was 
corroborated by AF1q overexpression results which showed an increased TCF7 
mRNA expression (Zhang et al., 2017). Furthermore, knocking down TCF7 in 
cells resulted in the elimination of the AF1q-mediated increase of β-catenin 
(Zhang et al., 2017). These findings support the hypothesis that AF1q interacts 
with the β-catenin-mediated Wnt pathway to induce kidney damage.  
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Given these findings, further studies of how AF1q and the Wnt pathway 
interact would support improved understanding of podocyte pathogenesis, as 
well as possible therapeutics for kidney disease. Moreover, these studies would 
help to clarify how AF1q influences neurodevelopment through Wnt signaling.  
Figure 15. AF1q enhances the Wnt/-catenin pathway. (A) Compared 
with the control, mouse podocyte (MPC5) cells with AF1q overexpression 
had significantly higher luciferase activity. This activity, measured by a 
luciferase reporter containing T-cell specific transcription factor (TCF) 
binding sites, indicates increased activity of the Wnt/β-catenin pathway in 
cells with overexpressed AF1q. (B) Compared with the control, MPC5 cells 
with AF1q overexpression had higher levels of β-catenin and tubulin. This 
indicates that AF1q not only induces podocyte injury but also upregulates 
the Wnt/β-catenin pathway. AF1q = ALL1-fused gene from chromosome 
1q; CON = control; MPC5 = mouse podocyte cell 5; Wnt = 
wingless/integrated. Plotted values = mean ± SD; **p < 0.01. Figure taken 
from (Zhang et al., 2017).   
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AF1q and Breast Cancer by the Wnt Pathway  
In a study by Park and co-workers (2015), AF1q was also found to interact 
with TCF7 to enhance the canonical Wnt signaling pathway and thus promote 
breast cancer metastasis. In particular, AF1q was proposed to be a co-factor 
acting within the TCF7/-catenin transcriptional complex. Immunoprecipitation 
studies  confirmed the interaction between AF1q and TCF7 (Figure 16A), and a 
protein-protein interaction model suggested that TCF7 forms a unique shape into 
which AF1q is fully enveloped (Figure 16B) (Park et al., 2015).  
Figure 16. AF1q is a cofactor of TCF7. (A) Western blot analysis shows that 
AF1q and T-cell specific transcription factor 7 (TCF7) co-immunoprecipitated 
when using an anti-AF1q antibody. This provides evidence that AF1q and 
TCF7 interact. (B) Based on a computational model, the three-dimensional 
shapes of AF1q and TCF7 were proposed. This model shows that TCF7 has a 
glove-like shape that surrounds AF1q. This supports the idea that AF1q forms 
a transcriptional complex with TCF7 by acting as a cofactor. AF1q = ALL1-
fused gene from chromosome 1q; IP = immunoprecipitation; NC = negative 
control. Figure taken from (Park et al., 2015). 
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Increased Wnt signaling activity was noted with forced AF1q 
overexpression in both normal breast epithelial cells and breast cancer cells, 
further supporting the possibility of AF1q acting as a co-factor in the Wnt 
pathway (Figure 17) (Park et al., 2015). CD44, a downstream target of the Wnt 
signaling pathway, has been associated with breast cancer and acute myeloid 
leukemia. AF1q overexpression is associated with increased CD44 expression, 
whereas AF1q suppression is associated with decreased CD44 expression (Park 
et al., 2015). Thus, the relationship between AF1q and CD44 is of interest. Despite 
overexpression of AF1q, the normal behavior of cancer cells and metastasis was 
reversed by knocking down CD44 in breast cancer cells and normal breast 
epithelial cells (Park et al., 2015). The study of AF1q in association with breast 
cancer metastasis has elucidated the important relationship between AF1q and 
Wnt signaling. AF1q not only interacts with TCF7 in a specific manner to 
regulate the Wnt pathway but also contributes to CD44 activation. Clearly, AF1q 
has a complex relationship with the Wnt signaling pathway that is linked to its 
oncogenic function.  
The Wnt signaling pathway is involved in numerous biological processes. 
This pathway has been extensively studied for its integral role in the 
development of the nervous system. AF1q has been found to act on the Wnt 
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signaling pathway to induce both kidney damage and breast cancer metastasis. 
Thus far, there have been no studies demonstrating the action of AF1q on the 
Wnt signaling pathway to influence neurodevelopmental processes. However, 
given the clear link between AF1q and Wnt signaling, as well as the importance 
of Wnt signaling during neurodevelopment, it can be hypothesized that AF1q 
may influence neurodevelopment through Wnt signaling pathways. Further 
studies are needed to explore this hypothesis.  
  
Figure 17. AF1q enhances Wnt signaling activity.  Relative Wnt activity was 
examined using the TOP/FOP flash reporter assays in breast cancer cell lines 
(MCF10a and MDA-MB-231). When AF1q was overexpressed, there was a 
significant increase in Wnt activity in both cell lines. When AF1q was 
silenced using short hairpin RNA (shRNA), Wnt activity was decreased in 
comparison with the scrambled RNA (Scr) control. AF1q = ALL1-fused gene 
from chromosome 1q; Con = control. Plotted values = mean ± SD (n = 3); *p < 
0.05, **p < 0.01. Figure taken from (Park et al., 2015).   
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CONCLUSION AND FUTURE DIRECTIONS 
 
The human brain is one of the most complex organs of the body. 
Consequently, its development is an equally complex process about which much 
is yet to be understood. An in-depth understanding of the development of the 
nervous system is critical for several reasons. First, it can allow better 
comprehension of neurodevelopmental disorders, such as Down syndrome and 
Alzheimer’s disease, to generate methods of prevention and therapy. Second, it 
can provide insight into the formation and progression of malignancies of 
neuronal and non-neuronal origin. Lastly, it can contribute to improving 
knowledge about the numerous molecules, proteins, and pathways that are 
involved in normal human development. 
AF1q has been widely explored as an oncogene, and its role in various 
solid neoplasms has been investigated. However, its role in normal 
neurodevelopment is still unclear. AF1q was found to be differentially expressed 
throughout neuronal maturation in various regions of the brain. It was also 
shown to be capable of transforming non-neuronal human embryonic kidney 
cells into neurons, implicating a possible critical role in neuronal differentiation. 
Furthermore, AF1q was discovered to be involved with REST and the Wnt 
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signaling pathway, both of which are normal players in the regulation of 
neurodevelopment. Although numerous studies have demonstrated that AF1q is 
involved in human neurodevelopment, there is a clear need for further 
investigation to understand the precise role of AF1q in the development of the 
nervous system.   
In the future, it would be interesting to conduct various phenotyping 
experiments to further investigate the role of AF1q. By utilizing mice with AF1q 
selectively knocked out, a study could analyze the brains at physical and 
molecular levels throughout development. In doing so, such studies could 
continue the observations regarding the effects of AF1q in neurodevelopment. In 
addition, behavioral studies, such as the Morris water maze, the grip strength 
test, and the elevated plus maze, could be conducted on AF1q knockout mice to 
study memory, cognition, anxiety, and social behavior. Comparison of the results 
of AF1q knockout mice with those of normal mice would help elucidate the 
phenotype of AF1q. Furthermore, the AF1q knockout mice could be aged and 
then studied histologically and physically to investigate the function of AF1q in 
post-embryonic neurodevelopment. It would be insightful to compare the 
incidence of neurodevelopmental diseases, such as Down syndrome and 
Alzheimer’s disease, in AF1q knockout mice versus normal mice.     
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 Given the association of AF1q with various hematological malignancies, 
cancers, and neurodevelopment, a precise comprehension of AF1q is critical. As 
understanding of AF1q improves, the increased knowledge of its biological and 
physiological functions is likely to lead to improved therapeutic treatments and 
drugs that target several malignancies. Thus, further investigation of the role of 
AF1q in neurodevelopment is clearly necessary.     
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